13F

ICCC IMMUCELL CORP

2026Q1 · CUSIP 452525306 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
27
Δ holders QoQ
+1
Breadth percentile
n/a
Whale holders
11
Δ whales
+1
Inst. holding value
$9M
New positions
5
Closed positions
4
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ-3 · h=16 2018Q2: Δ+2 · h=18 2018Q3: Δ+4 · h=22 2018Q4: Δ-2 · h=20 2019Q1: Δ+4 · h=24 2019Q2: Δ+0 · h=24 2019Q3: Δ-1 · h=23 2019Q4: Δ+1 · h=24 2020Q1: Δ-2 · h=22 2020Q2: Δ+3 · h=25 2020Q3: Δ+2 · h=27 2020Q4: Δ-2 · h=25 2021Q1: Δ+3 · h=28 2021Q2: Δ+1 · h=29 2021Q3: Δ+0 · h=29 2021Q4: Δ+2 · h=31 2022Q1: Δ-3 · h=28 2022Q2: Δ+2 · h=30 2022Q3: Δ-3 · h=27 2022Q4: Δ+0 · h=27 2023Q1: Δ+4 · h=31 2023Q2: Δ+1 · h=32 2023Q3: Δ-1 · h=31 2023Q4: Δ-3 · h=28 2024Q1: Δ-3 · h=25 2024Q2: Δ+3 · h=28 2024Q3: Δ-5 · h=23 2024Q4: Δ+4 · h=27 2025Q1: Δ+1 · h=28 2025Q2: Δ-2 · h=26 2025Q3: Δ+1 · h=27 2025Q4: Δ-1 · h=26 2026Q1: Δ+1 · h=27 2018Q1: holders=16 2018Q2: holders=18 2018Q3: holders=22 2018Q4: holders=20 2019Q1: holders=24 2019Q2: holders=24 2019Q3: holders=23 2019Q4: holders=24 2020Q1: holders=22 2020Q2: holders=25 2020Q3: holders=27 2020Q4: holders=25 2021Q1: holders=28 2021Q2: holders=29 2021Q3: holders=29 2021Q4: holders=31 2022Q1: holders=28 2022Q2: holders=30 2022Q3: holders=27 2022Q4: holders=27 2023Q1: holders=31 2023Q2: holders=32 2023Q3: holders=31 2023Q4: holders=28 2024Q1: holders=25 2024Q2: holders=28 2024Q3: holders=23 2024Q4: holders=27 2025Q1: holders=28 2025Q2: holders=26 2025Q3: holders=27 2025Q4: holders=26 2026Q1: holders=27 -5 -2.5 +0 +2.5 +5 142434 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.07
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.09 2022-09-30: EPS -0.08 2022-12-31: EPS -0.22 2023-03-31: EPS -0.30 2023-06-30: EPS -0.18 2023-09-30: EPS -0.12 2023-12-31: EPS -0.15 2024-03-31: EPS -0.06 2024-06-30: EPS -0.20 2024-09-30: EPS -0.09 2024-12-31: EPS 0.09 2025-03-31: EPS 0.16 2025-06-30: EPS 0.06 2025-09-30: EPS -0.02 2025-12-31: EPS -0.32 2026-03-31: EPS 0.21 -0.35 -0.06 0.23 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 2025-06-30: PE 27.72025-09-30: PE 18.6 17 23 29 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)